Analogue-based drug discovery III / edited by János Fischer, C. Robin Ganellin, David P. Rotella. [electronic resource] Analogue-based drug discovery 3 Analog-based drug discovery III Fischer, János, editor. Ganellin, C. R. (C. Robin), editor. Rotella, David P., editor. Drug development. RM301.25 .A53 2013 615.1/9 23 Includes bibliographical references and index. Online resource; title page from PDF title page (viewed June 30, 2014). "Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and--together with the previous volumes--constitutes the first systematic approach to drug analogue development"--Publisher's website. 2013 Text 1 online resource (xviii, 385 pages) : http://onlinelibrary.wiley.com/book/10.1002/9783527651085 eng Analogue-based drug discovery III. Analogue-based drug discovery III.